132 related articles for article (PubMed ID: 21225102)
1. The newer direct oral anticoagulants: a practical guide.
Thachil J
Clin Med (Lond); 2014 Apr; 14(2):165-75. PubMed ID: 24715128
[TBL] [Abstract][Full Text] [Related]
2. Stroke Prevention in Subclinical Atrial Fibrillation.
Allen AL; Kibert J; Wall TS
N Engl J Med; 2024 Apr; 390(15):1441-1442. PubMed ID: 38631012
[No Abstract] [Full Text] [Related]
3. Stroke Prevention in Subclinical Atrial Fibrillation.
Lee TC; Kaul S; Mandrola J
N Engl J Med; 2024 Apr; 390(15):1441. PubMed ID: 38631011
[No Abstract] [Full Text] [Related]
4. Stroke Prevention in Subclinical Atrial Fibrillation. Reply.
Healey JS; Lopes RD
N Engl J Med; 2024 Apr; 390(15):1442. PubMed ID: 38631013
[No Abstract] [Full Text] [Related]
5. Patient-Centered Rocket Science: Accurate but Imprecise.
Bakal JA; Wilber D
J Am Heart Assoc; 2024 Jun; 13(11):e035100. PubMed ID: 38780174
[No Abstract] [Full Text] [Related]
6. An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays.
Cini M; Legnani C; Testa S; Tripodi A; Cosmi B; Palareti G
Int J Lab Hematol; 2019 Jun; 41(3):309-315. PubMed ID: 30698331
[TBL] [Abstract][Full Text] [Related]
7. Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants.
Mitrousi K; Lip GYH; Apostolakis S
J Atr Fibrillation; 2013; 6(1):783. PubMed ID: 28496851
[TBL] [Abstract][Full Text] [Related]
8. Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.
Lega JC; Bertoletti L; Gremillet C; Chapelle C; Mismetti P; Cucherat M; Vital-Durand D; Laporte S;
PLoS One; 2014; 9(3):e91398. PubMed ID: 24622012
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.
Kasmeridis C; Apostolakis S; Ehlers L; Rasmussen LH; Boriani G; Lip GY
Pharmacoeconomics; 2013 Nov; 31(11):971-80. PubMed ID: 24085625
[TBL] [Abstract][Full Text] [Related]
10. The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia.
Guo Y; Lip GY; Apostolakis S
Malays J Med Sci; 2012 Jul; 19(3):1-7. PubMed ID: 23610543
[TBL] [Abstract][Full Text] [Related]
11. Medical management of venous thromboembolism: what the interventional radiologist needs to know.
Kasthuri RS; Key NS
Semin Intervent Radiol; 2012 Mar; 29(1):3-9. PubMed ID: 23449379
[TBL] [Abstract][Full Text] [Related]
12. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk.
Charidimou A; Shakeshaft C; Werring DJ
Front Neurol; 2012; 3():133. PubMed ID: 23015806
[TBL] [Abstract][Full Text] [Related]
13. The management of stroke in antiphospholipid syndrome.
Panichpisal K; Rozner E; Levine SR
Curr Rheumatol Rep; 2012 Feb; 14(1):99-106. PubMed ID: 22109663
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.
Pink J; Lane S; Pirmohamed M; Hughes DA
BMJ; 2011 Oct; 343():d6333. PubMed ID: 22042753
[TBL] [Abstract][Full Text] [Related]
15. Hotline update of clinical trials and registries presented at the 77th spring meeting of the German Society of Cardiology 2011.
Sinning JM; Walenta K; Werner N; Böhm M
Clin Res Cardiol; 2011 Jul; 100(7):553-60. PubMed ID: 21656190
[TBL] [Abstract][Full Text] [Related]
16. Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
Contractor T; Khasnis A
Cardiol Res Pract; 2011 Mar; 2011():752808. PubMed ID: 21559225
[TBL] [Abstract][Full Text] [Related]
17. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Ahrens I; Lip GY; Peter K
Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
[No Abstract] [Full Text] [Related]
18. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
